Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Evolus Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EOLS
Nasdaq
8731
https://www.evolus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Evolus Inc
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- May 10th, 2024 10:55 pm
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
- May 10th, 2024 1:10 pm
Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
- May 9th, 2024 11:31 am
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript
- May 8th, 2024 3:09 pm
Q1 2024 Evolus Inc Earnings Call
- May 8th, 2024 11:24 am
Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...
- May 8th, 2024 7:53 am
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
- May 7th, 2024 10:35 pm
Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth
- May 7th, 2024 9:46 pm
Evolus Reports First Quarter 2024 Results and Provides Business Update
- May 7th, 2024 8:05 pm
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59%
- May 3rd, 2024 3:05 pm
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?
- May 1st, 2024 6:29 am
Evolus to Report First Quarter Financial Results on May 7, 2024
- Apr 23rd, 2024 8:30 pm
11 Best Low Price Pharma Stocks To Invest In
- Apr 21st, 2024 2:39 pm
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®
- Apr 17th, 2024 8:05 pm
Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company
- Apr 6th, 2024 1:57 pm
Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Mar 26th, 2024 12:00 pm
10 Stocks George Soros and Insiders Are Crazy About
- Mar 14th, 2024 11:04 am
Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?
- Mar 13th, 2024 1:55 pm
Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
- Mar 11th, 2024 11:00 am
Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report
- Mar 10th, 2024 1:16 pm
Scroll